1. First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial. (October 2020) Authors: Jordan, Jarrat; Benson, Jacqueline; Chatham, Walter Winn; Furie, Richard Alan; Stohl, William; Wei, James Cheng-Chung; Marciniak, Stanley; Yao, Zhenling; Srivastava, Bhaskar; Schreiter, Jessica; Cesaroni, Matteo; Orillion, Ashley; Seridi, Loqmane; Chevrier, Marc Journal: Lancet Issue: Volume 2:Number 10(2020) Page Start: e613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma. Issue 1 (December 2016) Authors: Ramakrishnan, Swathi; Ku, ShengYu; Ciamporcero, Eric; Miles, Kiersten; Attwood, Kris; Chintala, Sreenivasulu; Shen, Li; Ellis, Leigh; Sotomayor, Paula; Swetzig, Wendy; Huang, Ray; Conroy, Dylan; Orillion, Ashley; Das, Gokul; Pili, Roberto Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Histone deacetylase inhibitors as immunomodulators in cancer therapeutics. (March 2016) Authors: Shen, Li; Orillion, Ashley; Pili, Roberto Journal: Epigenomics Issue: Volume 8:Number 3(2016) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. (April 2021) Authors: Seridi, Loqmane; Cesaroni, Matteo; Orillion, Ashley; Schreiter, Jessica; Chevrier, Marc; Marciniak, Stanley; Migone, Thi-Sau; Stohl, William; Chatham, Walter Winn; Furie, Richard Alan; Benson, Jacqueline; Jordan, Jarrat Journal: Lupus Issue: Volume 30:Number 5(2021) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus. Issue 3 (1st February 2021) Authors: Cesaroni, Matteo; Seridi, Loqmane; Loza, Matthew J.; Schreiter, Jessica; Sweet, Kristen; Franks, Carol; Ma, Keying; Orillion, Ashley; Campbell, Kim; M. Gordon, Robert; Branigan, Patrick; Lipsky, Peter; van Vollenhoven, Ronald; Hahn, Bevra H.; Tsokos, George C.; Chevrier, Marc; Rose, Shawn; Bariba... Journal: Arthritis & rheumatology Issue: Volume 73:Issue 3(2021) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗